JSMD Overview

ETF Performance Analysis: The Janus Henderson Small/Mid Cap Growth Alpha ETF (JSMD) has an implied analyst target price of $92.46, indicating a potential upside of 9.56% from its current trading price of $84.39.

Notable Holdings with Upside: Key underlying holdings of JSMD, such as Stoke Therapeutics Inc (STOK), Healthcare Services Group, Inc. (HCSG), and Wayfair Inc (W), show significant upside potential based on analyst target prices.

Analyst Target Justification: The article raises questions about whether analysts' target prices are justified or overly optimistic, suggesting that high targets could lead to downgrades if they do not align with recent developments.

Investor Research Importance: Investors are encouraged to conduct further research to assess the validity of analyst targets and their implications for future stock performance.

ETF Performance Overview: The Janus Henderson Small/Mid Cap Growth Alpha ETF (JSMD) has an implied analyst target price of $90.32 per unit, indicating a potential upside of 9.50% from its recent trading price of $82.48.

Notable Holdings with Upside: Key underlying holdings of JSMD, such as Tidewater Inc (TDW), Kontoor Brands Inc (KTB), and REV Group Inc (REVG), show significant upside potential based on analyst target prices, with TDW having a target price 38.20% higher than its current price.

Analyst Target Justification: The article raises questions about whether analysts' target prices are justified or overly optimistic, suggesting that high targets could lead to future downgrades if they do not align with recent developments.

Investor Research Recommendation: Investors are encouraged to conduct further research to assess the validity of analyst targets and their alignment with current company and industry trends.

ETF Performance: The Janus Henderson Small/Mid Cap Growth Alpha ETF is down approximately 4% in Friday afternoon trading, underperforming other ETFs.

Weakest Components: Notable declines within the ETF include Contineum Therapeutics, which fell by about 6.9%, and International Money Express, which decreased by about 5.8%.

Fabrinet's Q3 FY25 Results: Fabrinet reported third-quarter revenue of $871.8 million and adjusted EPS of $2.52, both exceeding expectations. The company anticipates fourth-quarter revenue between $860 million and $900 million, also above market forecasts.

Analyst Outlook: Analyst Mike Genovese raised the price target for Fabrinet from $230 to $250, citing a strong outlook in the Telecom sector and potential benefits from contracts with major companies, despite expected weaker performance in the Datacom segment.

Overview of JSMD ETF: The Janus Henderson Small/Mid Cap Growth Alpha ETF (JSMD), launched in 2016, aims to provide broad exposure to small-cap growth stocks and has over $378 million in assets, with a focus on healthcare, industrials, and technology sectors.

Performance and Comparison: As of September 2024, JSMD has shown positive returns of 9.39% year-to-date and 21.55% over the past year, but investors may also consider other ETFs like iShares Russell 2000 Growth ETF and Vanguard Small-Cap Growth ETF for potentially lower costs and risks.

Overview of Janus Henderson Small/Mid Cap Growth Alpha ETF (JSMD): Launched in 2016, JSMD is a passively managed ETF focusing on small-cap growth stocks, with assets over $372.75 million and an expense ratio of 0.30%. It aims to match the performance of the Janus Small/Mid Cap Growth Alpha Index and has shown positive returns of 8.40% this year and 15.15% over the past year.

Investment Considerations: While JSMD offers diversified exposure to small-cap growth companies, it carries higher risks due to market volatility. Investors should also consider other ETFs like iShares Russell 2000 Growth ETF and Vanguard Small-Cap Growth ETF, which have larger asset bases and lower expense ratios.